© 2023 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#Faslodex

Capivasertib Delays Disease Progression in People With Advanced Breast Cancer

Adding an AKT inhibitor to fulvestrant doubled progression-free survival for patients with HR-positive, HER2-negative breast cancer.
Jersi Baker

A Breast Cancer Diary: Angela Baker

Angela “Jersi” Baker, 48, of Charlotte, North Carolina, has found a new life as a model promoting metastatic breast cancer awareness.

FDA Approves New Targeted Therapy for Advanced Breast Cancer

Piqray plus Faslodex prolonged progression-free survival for metastatic breast cancer patients with PIK3CA gene mutation.
David Barrett, MD

New Studies Shed Light on Cancer Treatment Failure

Coming up at AACR: Chemotherapy can compromise CAR-T therapy and HER2 mutations may confer resistance to hormone therapy.

Faslodex

Advertisement

Cancer Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

Cancer Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.